Transplantation for chronic myelogenous leukemia: yes, no, maybe so…an Oregon perspective
Open Access
- 27 August 2003
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (5) , 459-469
- https://doi.org/10.1038/sj.bmt.1704163
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Leukemia cells eat their VEGFtablesBlood, 2002
- Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell doseBlood, 2002
- Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II studyBlood, 2002
- Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyBlood, 2002
- STI571: A Paradigm of New Agents for Cancer TherapeuticsJournal of Clinical Oncology, 2002
- Chronic Myelogenous LeukemiaHematology-American Society Hematology Education Program, 2002
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1997
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996